Canature Health Technology Co., Ltd. completed the acquisition of 12.87% stake in Shanghai Origincell Biological Cryo Equipment Co., Ltd. from Shanghai Senba Investment Center (Limited Partnership) and Shanghai Senlu Investment Center (Limited Partnership) on November 27, 2023.
November 26, 2023
Share
Canature Health Technology Co., Ltd. (SZSE:300272) agreed to acquire additional 12.87% stake in Shanghai Origincell Biological Cryo Equipment Co., Ltd. from Shanghai Senba Investment Center (Limited Partnership) and Shanghai Senlu Investment Center (Limited Partnership) for CNY 270 million on October 10, 2023. As of June 30, 2023, Shanghai Origincell Biological Cryo Equipment Co., Ltd reported total assets of CNY 1.6 billion and net assets of CNY 990 million. The deal has been approved by board of directors and is subject to approval from shareholders of Canature Health Technology Co., Ltd.
Canature Health Technology Co., Ltd. (SZSE:300272) completed the acquisition of 12.87% stake in Shanghai Origincell Biological Cryo Equipment Co., Ltd. from Shanghai Senba Investment Center (Limited Partnership) and Shanghai Senlu Investment Center (Limited Partnership) on November 27, 2023.
Canature Health Technology Co Ltd is a China-based company mainly engaged in the manufacturing of water treatment products. The Company is committed to the research, development, manufacturing, sales and services of residential water treatment products and core components such as whole-house water purifiers, whole-house water softeners, commercial purified water dispensers, RO membrane reverse osmosis water purifiers, multi-way control valves, composite material pressure vessels, and membrane elements. The Company provides customized water solutions including residential water solutions, commercial water solutions, public facilities water solutions, industrial water and other special conditions. The Company sells its products domestically in China as well as in overseas markets including Europe, North America and other parts of Asia.
Canature Health Technology Co., Ltd. completed the acquisition of 12.87% stake in Shanghai Origincell Biological Cryo Equipment Co., Ltd. from Shanghai Senba Investment Center (Limited Partnership) and Shanghai Senlu Investment Center (Limited Partnership) on November 27, 2023.
CANATURE HEALTH TECHNOLOGY CO., LTD. 
